Kymera Therapeutics Inc Asset Turnover Ratio (KYMR), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kymera Therapeutics Inc   (NASDAQ: KYMR)
 

Kymera Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Kymera Therapeutics Inc asset turnover ratio, the ability of Kymera Therapeutics Inc 's assets to generate revenue in the second quarter 2026, increased sequentially to 0.07 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as KYMR's position remain challenging.

Within sector 16 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 2595 to 2967.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYMR Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 45.48 % 81.75 % 87.84 % 12.23 % 46.02 %
Y / Y Revenue Change 466.4 % 55.5 % -61.17 % -26.12 % -55.26 %
Asset Turnover Ratio (TTM) 0.07 0.04 0.03 0.04 0.05
KYMR's Total Ranking # 2967 # 2595 # 2409 # 2210 # 2983
Seq. Asset Change -1.41 % -4.23 % 58.14 % -2.57 % 23.17 %
Seq. Revenue Change 89.15 % 1096.97 % 3.87 % -75.91 % -48.07 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 17
Healthcare Sector # 107
Overall Market # 2967

Asset Turnover Ratio Statistics
High Average Low
103.9 21.97 3.43
(Jun 30 2021)   (Mar 31 2026)




KYMR Company Profile • Back to KYMR Efficiency Comparisons • Compare KYMR Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Ligand Pharmaceuticals Incorporated  0.17 $ 290.542  Millions$ 1,688.847  Millions
Septerna Inc   0.17 $ 98.882  Millions$ 584.816  Millions
Inspiremd Inc   0.17 $ 10.502  Millions$ 62.247  Millions
Coherus Oncology inc   0.17 $ 50.936  Millions$ 308.017  Millions
Prelude Therapeutics Inc  0.16 $ 22.424  Millions$ 136.269  Millions
Prothena Corporation Public Limited Company  0.16 $ 54.530  Millions$ 332.976  Millions
Wave Life Sciences Ltd   0.16 $ 81.746  Millions$ 505.436  Millions
Opus Genetics Inc   0.16 $ 9.856  Millions$ 61.530  Millions
Skinvisible Inc   0.16 $ 0.020  Millions$ 0.126  Millions
Maxcyte inc   0.16 $ 31.051  Millions$ 198.782  Millions
Abeona Therapeutics Inc   0.15 $ 30.093  Millions$ 207.166  Millions
Voyager Therapeutics Inc   0.14 $ 34.459  Millions$ 239.417  Millions
Standard Biotools Inc   0.14 $ 83.691  Millions$ 593.430  Millions
Femasys Inc   0.14 $ 2.299  Millions$ 16.450  Millions
Seastar Medical Holding Corp  0.14 $ 1.713  Millions$ 12.400  Millions
Sintx Technologies Inc   0.14 $ 1.330  Millions$ 9.778  Millions
Xencor Inc  0.13 $ 104.973  Millions$ 801.528  Millions
Lucid Diagnostics Inc   0.13 $ 5.445  Millions$ 41.667  Millions
Royalty Pharma Plc  0.13 $ 2,535.998  Millions$ 19,650.812  Millions
Omniab Inc   0.13 $ 38.457  Millions$ 298.628  Millions
Lineage Cell Therapeutics Inc   0.13 $ 13.083  Millions$ 104.494  Millions
Igc Pharma Inc   0.12 $ 1.101  Millions$ 9.293  Millions
Kura Oncology Inc   0.12 $ 77.225  Millions$ 657.022  Millions
Arcus Biosciences Inc   0.12 $ 117.000  Millions$ 1,008.500  Millions
Arcturus Therapeutics Holdings Inc   0.11 $ 29.368  Millions$ 255.803  Millions
China Pharma Holdings Inc  0.11 $ 3.914  Millions$ 34.164  Millions
Pmgc Holdings Inc   0.11 $ 2.579  Millions$ 22.601  Millions
Tonix Pharmaceuticals Holding Corp   0.11 $ 29.102  Millions$ 260.403  Millions
Beam Therapeutics Inc   0.11 $ 156.035  Millions$ 1,414.853  Millions
Surrozen Inc   0.11 $ 11.511  Millions$ 107.272  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.